Bodycad announced today that it has received a Health Canada medical device license and clearance to sell the Bodycad OnCall™ personalized cutting guides.
Bodycad has announced an exclusive agreement with OrthoGrow, a Belgian based company, for distribution and consulting services of its personalized orthopaedic knee products for the European Union.
Bodycad was featured in the latest edition of the BONEZONE magazine.
Bodycad has named orthopaedic executive, Steve Pruitt as its Vice President of Sales – US. Steve is a senior level executive with more than 20 years of successful medical device experience in start-ups and orthopaedics.
Bodycad has announced that the first personalized restoration procedures using its Unicompartmental Knee System in patients have been successfully performed.
Bodycad announced today that it has received product notification confirmation from the Belgian Federal Agency for Medicines and Health Products in Brussels, the legislative capital for the European Union, for its Bodycad Unicompartmental Knee System.
Bodycad announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Bodycad Unicompartmental Knee System, enabling the commercial launch of this truly personalized orthopaedic restoration.
Bodycad announced it has been awarded two key US patents for improving the accuracy, reproducibility and speed for 3D constructs via MRI and CT images in long and small bone orthopaedic applications.
Bodycad has named former American Academy of Orthopaedic Surgeons (AAOS) President Daniel Berry, M.D. as its Chief Science Advisor.
Bodycad featured in the Summer 2016 edition of the COA Bulletin.
Bodycad will exhibit at the Canadian Orthopaedic Association (COA) Annual Meeting, June 16 to 19, 2016.
Bodycad has announced the introduction of Bodycad OnCall, its personalized, individually manufactured orthopaedic restorations for complex cases.